X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1035) 1035
Publication (129) 129
Book Review (18) 18
Book Chapter (12) 12
Dissertation (12) 12
Book / eBook (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (592) 592
index medicus (535) 535
glucagon-like peptide-2 (531) 531
humans (486) 486
male (345) 345
rats (257) 257
endocrinology & metabolism (221) 221
glucagon-like peptide 2 (213) 213
mice (198) 198
female (196) 196
gastroenterology & hepatology (195) 195
glucagon-like peptide-1 (189) 189
glucagon (175) 175
peptides (168) 168
glp-2 (158) 158
physiology (147) 147
glucagon-like peptides (128) 128
nutrition & dietetics (117) 117
physiological aspects (110) 110
secretion (110) 110
glucose (106) 106
short bowel syndrome (105) 105
glucagon-like peptide 2 - pharmacology (104) 104
insulin (103) 103
short-bowel syndrome (102) 102
digestive, oral, and skin physiology (99) 99
glucagon-like peptide 1 (96) 96
peptides - pharmacology (95) 95
research (93) 93
obesity (91) 91
health aspects (90) 90
adult (89) 89
expression (89) 89
intestinal adaptation (89) 89
pharmacology & pharmacy (89) 89
glucagon-like peptide 2 - metabolism (86) 86
adaptation (85) 85
growth (85) 85
intestinal mucosa - metabolism (85) 85
proliferation (84) 84
rats, sprague-dawley (84) 84
intestine (83) 83
diabetes (81) 81
receptor (79) 79
surgery (79) 79
middle aged (78) 78
disease models, animal (76) 76
proglucagon (75) 75
in-vivo (73) 73
parenteral nutrition (72) 72
receptors, glucagon - metabolism (72) 72
rat (71) 71
analysis (70) 70
glucagon-like peptide-1 receptor (70) 70
biochemistry & molecular biology (69) 69
endocrine system (69) 69
glp-1 (67) 67
glucagon-like peptide-2 receptor (66) 66
intestinal failure (66) 66
rodents (66) 66
abridged index medicus (65) 65
hormones, hormone substitutes, and hormone antagonists (65) 65
intestinal mucosa - drug effects (65) 65
teduglutide (65) 65
article (63) 63
gene-expression (63) 63
swine (63) 63
mice, inbred c57bl (62) 62
rats, wistar (62) 62
apoptosis (61) 61
resection (59) 59
metabolism (58) 58
gene expression (57) 57
signal transduction (57) 57
food-intake (56) 56
absorption (55) 55
short bowel syndrome - physiopathology (55) 55
type 2 diabetes (55) 55
cells (54) 54
glucagon-like peptide 2 - blood (54) 54
inflammation (54) 54
nutrition (54) 54
diet (53) 53
intestines - metabolism (53) 53
enteric neurons (52) 52
glp-2 receptor (52) 52
intestine, small - drug effects (51) 51
peptides - therapeutic use (51) 51
dose-response relationship, drug (50) 50
hormones (50) 50
pediatrics (50) 50
peptides - metabolism (50) 50
short bowel syndrome - drug therapy (50) 50
glucagon-like peptide 1 - metabolism (49) 49
inflammatory-bowel-disease (49) 49
medicine & public health (49) 49
adaptation, physiological (48) 48
agriculture, dairy & animal science (47) 47
blood-flow (47) 47
intestine, small - metabolism (47) 47
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1037) 1037
Chinese (5) 5
Japanese (3) 3
Spanish (3) 3
Croatian (1) 1
Czech (1) 1
French (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Physiology - Gastrointestinal and Liver Physiology, ISSN 0193-1857, 07/2011, Volume 301, Issue 1, pp. G1 - G8
Rowland KJ, Brubaker PL. The "cryptic" mechanism of action of glucagon-like peptide-2. Am J Physiol Gastrointest Liver Physiol 301: G1-G8, 2011. First... 
Colon cancer | Proliferation | Intestine | Growth factors | Stem cells | stem cells | SIGNALING PATHWAYS | STEM-CELLS | PHYSIOLOGY | intestine | growth factors | proliferation | colon cancer | PHOSPHATIDYLINOSITOL 3-KINASE | MURINE SMALL-INTESTINE | ANTIINFLAMMATORY ACTIONS | SMALL-BOWEL | BLOOD-FLOW | FACTOR RECEPTOR | GLP-2 RECEPTOR | GASTROENTEROLOGY & HEPATOLOGY | GROWTH-FACTOR-I | Intestines - drug effects | Receptors, Glucagon - agonists | Glucagon-Like Peptide-2 Receptor | Humans | Rats | Colonic Neoplasms - chemically induced | Cell Transformation, Neoplastic - chemically induced | Intestines - metabolism | Glucagon-Like Peptide 2 - therapeutic use | Stem Cells - metabolism | Glucagon-Like Peptide 2 - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Fibroblast Growth Factor 7 - metabolism | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Glucagon-Like Peptide 2 - pharmacology | Signal Transduction - drug effects | Vasoactive Intestinal Peptide - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Stem Cells - drug effects | Cell Proliferation - drug effects | Mice | Nitric Oxide - metabolism | Somatomedins - metabolism | Cell proliferation | Prevention | Physiological aspects | Genetic aspects | Research | Peptide hormones | Health aspects | Index Medicus
Journal Article
Journal Article
Journal Article
Clinical Nutrition, ISSN 0261-5614, 2013, Volume 32, Issue 5, pp. 713 - 721
Summary Background & aims Short bowel syndrome (SBS)-intestinal failure (IF) patients have impaired quality of life (QoL) and suffer from the burden of... 
Gastroenterology and Hepatology | Quality of life (QoL) | Teduglutide | Treatment response | Short bowel syndrome (SBS) | Glucagon-like peptide 2 (GLP-2) analogue | SUPPORT | NUTRITION & DIETETICS | HOME PARENTERAL-NUTRITION | ABSORPTION | INTESTINAL FAILURE | Glucagon-Like Peptide-2 Receptor | Intestine, Small - pathology | Humans | Middle Aged | Gastrointestinal Agents - administration & dosage | Cost of Illness | Glucagon-Like Peptide 2 - therapeutic use | Glucagon-Like Peptide 2 - adverse effects | Peptides - administration & dosage | Intestinal Diseases - physiopathology | Glucagon-Like Peptide 2 - administration & dosage | Short Bowel Syndrome - pathology | Injections, Subcutaneous | Short Bowel Syndrome - drug therapy | Short Bowel Syndrome - therapy | Adult | Glucagon-Like Peptide 2 - chemistry | Drug Resistance | Receptors, Glucagon - agonists | Short Bowel Syndrome - physiopathology | Double-Blind Method | Intestinal Diseases - drug therapy | Organ Size | Drinking | Intestine, Small - physiopathology | Intestinal Diseases - therapy | Gastrointestinal Agents - therapeutic use | Quality of Life | Organ Dysfunction Scores | Aged | Gastrointestinal Agents - adverse effects | Parenteral Nutrition, Home - adverse effects | Peptides - adverse effects | Peptides - therapeutic use | Intestinal Diseases - pathology | Medical colleges | Care and treatment | Glucagon | Malabsorption syndromes | Analysis
Journal Article
Journal Article
Current Opinion in Lipidology, ISSN 0957-9672, 06/2016, Volume 27, Issue 3, pp. 257 - 263
Journal Article
Peptides, ISSN 0196-9781, 09/2017, Volume 95, pp. 68 - 75
Journal Article
11/2011
Glucagon-like peptide-2 (GLP-2) is an intestinotrophic and intestinal anti-inflammatory hormone. Hence, I hypothesized that treatment with... 
Glucagon-like peptide-2 | Colon cancer | 0719
Dissertation
American Journal of Physiology - Gastrointestinal and Liver Physiology, ISSN 0193-1857, 05/2013, Volume 305, Issue 4, pp. G277 - G285
Short bowel syndrome (SBS) is a frequent complication after intestinal resection in infants suffering from intestinal disease. We tested whether treatment with... 
Premature | Neonatal short bowel syndrome | Glucagon-like peptide-2 | Intestine | NEWBORN PIGS | NUTRIENT ABSORPTION | PRESERVED COLON | PHYSIOLOGY | intestine | glucagon-like peptide-2 | neonatal short bowel syndrome | ILEOCECAL RESECTION | PROLIFERATION | BLOOD-FLOW | TOTAL PARENTERAL-NUTRITION | premature | SHORT-BOWEL SYNDROME | PIGLETS | GLP-2 | GASTROENTEROLOGY & HEPATOLOGY | Adaptation, Physiological | Intestine, Small - pathology | DNA Replication - drug effects | Humans | Intestinal Absorption - drug effects | Glucagon-Like Peptide 2 - pharmacology | Short Bowel Syndrome - pathology | Time Factors | Swine | Intestine, Small - growth & development | Short Bowel Syndrome - drug therapy | Weight Gain - drug effects | Nutritional Status | Short Bowel Syndrome - blood | Disease Models, Animal | Animals, Newborn | Short Bowel Syndrome - physiopathology | Premature Birth | Jejunostomy | Parenteral Nutrition, Total | Enteral Nutrition | Recombinant Proteins - pharmacology | Gestational Age | Animals | Intestine, Small - surgery | Animal Nutritional Physiological Phenomena | Short Bowel Syndrome - etiology | Glucagon-Like Peptide 2 - blood | Intestine, Small - drug effects | Protein Biosynthesis - drug effects | Cell Proliferation - drug effects | Intestine, Small - metabolism | Sucrase - metabolism | alpha-Glucosidases - metabolism | Physiological aspects | Peptides | Infants (Premature) | Malabsorption syndromes | Health aspects | Hormones and Signaling
Journal Article